project id: TCGA-LGG; case submitter id: TCGA-CS-6670; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.37; rna integrity number: 7.4; age at index: 43; days to birth: -16066; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1968; age at diagnosis: 16066; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1426.0; icd 10 code: C71.9; last known disease status: not reported; morphology: 9451/3; primary diagnosis: Oligodendroglioma, anaplastic; prior malignancy: yes; prior treatment: Yes; progression or recurrence: not reported; site of resection or biopsy: Brain, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Brain, NOS; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.8; longest dimension: 1.0; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-CS-6670-01A-11; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0;